The inspiration for IBM's foray into nanomedicine is twofold: our growing resistance to antibiotics and the incidence of medical-implant rejection by the human body. With this in mind, Hedrick and his team, leveraging IBM's background in semiconductor research, developed synthetic polymers that mimic the immune system. Using a simple charge, these resultant polymers are capable of hunting down and clinging to specific microbes throughout the body. And, once attached, cause those microbes to rupture as if they'd been hit by an explosive shuriken (or ninja star) -- hence, the name.
The inspiration for IBM's foray into nanomedicine is two-fold: our growing resistance to antibiotics and the incidence of medical-implant rejection.
Of course, anyone who's seen Innerspace knows there's a certain danger to injecting foreign objects into your body. But Hedrick says we have nothing to worry about. The ninja particles won't pass into other parts of the body. They're also proven to have a low toxicity and, best of all, won't engender a new wave of resistant pathogens (read: superbugs). So when will see the practical fruits of IBM's research? Well, Hedrick tells us the company's already in talks with various partners to apply this nanotech to our modern world in anything from medicine to the deodorant we use daily to the detergents we use to wash our clothes and kitchenware. And that future's not too far off, either -- Hedrick believes we could begin to see these ninja particle-infused products hit retail within a decade's time.
Watch Hedrick explain how IBM's research into ninja particles can help revolutionize the health care industry.
Stay tuned for part three of our inside look at IBM's Almaden research facility.
[Image credit: Laguna Design/Getty]